Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

ECG Interpretation of Arrhythmias I: Sinus Arrhythmias01:16

ECG Interpretation of Arrhythmias I: Sinus Arrhythmias

781
Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
781
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

410
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
410
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

283
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
283
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

208
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
208
Bacterial Signaling01:30

Bacterial Signaling

40.1K
Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
40.1K
Bacterial Transformation01:33

Bacterial Transformation

59.5K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
59.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal analysis of tyrosine kinase inhibitor therapy outcomes and BCR-ABL1 transcript decline velocity in chronic myeloid leukemia: A 16-year real-world study.

Cancer·2026
Same author

Cytokine receptor and JAK/STAT pathway mutations in acute myeloid leukemia: Prevalence and clinical impact.

Cancer·2026
Same author

Is there a best frontline therapy in chronic myeloid leukemia?

Haematologica·2025
Same author

Combining drugs that bypass p53 to treat TP53-mutated leukemias.

Blood advances·2025
Same author

A comparative assessment of molecular-based prognostic models in CMML.

Blood neoplasia·2025
Same author

Comparative Outcomes of Intensive Chemotherapy Versus Venetoclax Plus Hypomethylating Agents in Acute Myeloid Leukemia Patients Aged 60-75 Years: A Propensity Score-Adjusted Cohort Study.

Clinical lymphoma, myeloma & leukemia·2025

Related Experiment Video

Updated: Jan 21, 2026

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

14.5K

Cavernous Sinus Thrombosis due to Chronic Bacterial Sinusitis.

Summia Matin Afridi1, Myint Noe1, Ahmad Raja2

  • 1Internal Medicine, Florida Hospital, Orlando, USA.

Cureus
|July 30, 2019
PubMed
Summary

Septic cavernous sinus thrombosis, a rare infection, can arise from chronic bacterial sinusitis. This case highlights a potential complication of untreated sinus infections despite antibiotic availability.

Keywords:
bacterial sinusitiscavernous sinus thrombosisdiabetes mellitus complications

More Related Videos

Establishment of a Rat Model of Superior Sagittal-Sinus Occlusion via a Thread-Embolism Method
08:07

Establishment of a Rat Model of Superior Sagittal-Sinus Occlusion via a Thread-Embolism Method

Published on: July 4, 2021

4.0K
Formation of Human Prostate Epithelium Using Tissue Recombination of Rodent Urogenital Sinus Mesenchyme and Human Stem Cells
08:44

Formation of Human Prostate Epithelium Using Tissue Recombination of Rodent Urogenital Sinus Mesenchyme and Human Stem Cells

Published on: June 22, 2013

14.3K

Related Experiment Videos

Last Updated: Jan 21, 2026

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

14.5K
Establishment of a Rat Model of Superior Sagittal-Sinus Occlusion via a Thread-Embolism Method
08:07

Establishment of a Rat Model of Superior Sagittal-Sinus Occlusion via a Thread-Embolism Method

Published on: July 4, 2021

4.0K
Formation of Human Prostate Epithelium Using Tissue Recombination of Rodent Urogenital Sinus Mesenchyme and Human Stem Cells
08:44

Formation of Human Prostate Epithelium Using Tissue Recombination of Rodent Urogenital Sinus Mesenchyme and Human Stem Cells

Published on: June 22, 2013

14.3K

Area of Science:

  • Neurology
  • Infectious Diseases
  • Otolaryngology

Background:

  • The cavernous sinus is a common site for dural sinus infections and thrombosis.
  • Septic cavernous sinus thrombosis (SCST) incidence has decreased with antibiotic use.
  • Chronic bacterial sinusitis is a potential, though infrequent, cause of SCST.

Observation:

  • This report details a case of SCST.
  • The patient's SCST was attributed to chronic bacterial sinusitis.

Findings:

  • SCST can occur secondary to chronic bacterial sinusitis.
  • This presentation underscores the importance of recognizing sinus infections as a potential source for cavernous sinus thrombosis.

Implications:

  • Highlights a rare but serious complication of chronic sinusitis.
  • Emphasizes the need for vigilance in diagnosing and managing sinus infections to prevent intracranial complications.
  • Suggests that even with antibiotics, certain infections can lead to severe outcomes.